首页|结直肠癌组织中CCNA1、CDC20表达水平及临床预后意义

结直肠癌组织中CCNA1、CDC20表达水平及临床预后意义

扫码查看
目的 探讨结直肠癌(CRC)组织中细胞周期蛋白A1(CCNA1)、细胞分裂周期蛋白20(CDC20)表达水平及与患者临床表现、预后的关系.方法 选取2018年11月至2020年12月期间北京市平谷区医院收治的146例CRC患者作为研究对象,将手术取得癌组织标本纳入CRC组(n=146),将相对应的癌旁组织(离癌组织>3 cm)标本纳入癌旁组(n=146).采用免疫组化法检测组织中CCNA1、CDC20表达情况.通过χ2检验分析CCNA1、CDC20表达与CRC患者临床病理特征的关系,采用多因素Cox回归分析探讨CRC患者预后的相关因素.结果 CRC组CCNA1、CDC20的阳性表达率均高于癌旁组,差异有统计学意义(均P<0.05).分化程度为低分化、TNM分期为Ⅲ期、有神经侵犯的患者CCNA1阳性表达率、CDC20阳性表达率分别高于中/高分化、TNM分期Ⅰ~Ⅱ期、无神经侵犯患者,差异有统计学意义(均P<0.05).分化程度中/高分化、TNM分期为Ⅰ~Ⅱ期、无神经侵犯、CCNA1阴性、CDC20阴性患者3年生存率分别高于分化程度低分化、TNM分期Ⅲ期、有神经侵犯、CCNA1阳性、CDC20阳性患者,差异有统计学意义(均P<0.05).多因素Cox回归分析显示,低分化(HR=2.125,95%CI:1.406~3.214)、TNM分期Ⅲ期(HR=2.614,95%CI:1.504~4.544)、有神经侵犯(HR=2.337,95%CI:1.498~3.647)、CCNA1阳性(HR=2.765,95%CI:1.758~4.348)、CDC20阳性(HR=3.550,95%CI:2.075~6.074)是CRC患者预后的影响因素(P<0.05).结论 CCNA1、CDC20在CRC患者癌组织中均呈高表达,与肿瘤分期、分化程度密切相关,有望作为辅助评估CRC患者预后的潜在标记物.
The expression levels of CCNA1 and CDC20 in colorectal cancer tissues and their clinical prognostic significance
Objective To investigate the expression levels of cyclin A1(CCNA1)and cyclin D20(CDC20)in colorectal cancer(CRC)tissues and their relationship with clinical manifestations and prognosis of patients.Methods A total of 146 CRC patients were selected.The cancer tissue specimens obtained from surgical treatment were included in the CRC group(n=146)and the corresponding adjacent tissues(>3 cm from the cancer tissue)were included in the adjacent group(n=146).The expression of CCNA1 and CDC20 was detected by immunohistochemistry.The relationship between the CCNA1,CDC20 and clinicopathological features of CRC patients was analyzed by χ2 test,and the related factors for the prognosis of CRC patients were explored by multivariate Cox regression analysis.Results The positive expression rates of CCNA1 and CDC20 in the CRC group were higher than those in the adjacent group,and the difference was statistically sig-nificant(P<0.05).The positive expression rates of CCNA1 and CDC20 in patients with poorly differentiated degree,TNM stage Ⅲ,and nerve invasion were higher than those in patients with moderately/well differentiat-ed degrees,TNM stage Ⅰ~Ⅱ,and no nerve invasion,and the difference was statistically significant(P<0.05).The 3-year survival rate of patients with medium/high differentiation,TNM stage Ⅰ to Ⅱ,no nerve in-vasion,CCNA1 negative and CDC20 negative was higher than that of patients with low differentiation,TNM stage Ⅲ,nerve invasion,CCNA1 positive and CDC20 positive,respectively,and the difference was statisti-cally significant(P<0.05).Poorly differentiated CRC(HR=2.125,95%CI:1.406~3.214),TNM stage Ⅲ(HR=2.614,95%CI:1.504~4.544),nerve invasion(HR=2.337,95%CI:1.498~3.647),CCNA1 positive(HR=2.765,95%CI:1.758~4.348),CDC20 positive(HR=3.550,95%CI:2.075~6.074)were the prognostic factors of CRC patients(P<0.05).Conclusion CCNA1 and CDC20 are both highly expressed in CRC tis-sues and are closely associated with differentiation,TNM stage,and nerve invasion.They are expected to serve as potential markers to aid in the prognosis of CRC patients.

Colorectal cancerCyclin A1Cyclin D20

刘然、熊中原、王晓红

展开 >

北京市平谷区医院病理科,北京 101200

结直肠癌 细胞周期蛋白A1 细胞分裂周期蛋白20

北京市平谷区医院临床研究项目

MR-11-24-010563

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(5)
  • 3